NCT00075621
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,008 public trials
572 recruiting studies
Paraproteinemias trial results
NCT02178579
- Conditions
- Blood Protein Disorders, Cardiotoxicity, Cardiovascular Diseases, +21 more
- Locations
-
- University of Pennsylvania/Smilow Center for Translational Research Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT01090921
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Little Rock VA Medical Center Little Rock, Arkansas, United States
- West Los Angeles VA Medical Center Los Angeles, California, United States
- San Francisco VA Medical Center San Francisco, California, United States
- Eastern Colorado Health Care System Denver, Colorado, United States
NCT00718419
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Roche-sur-Yon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nantes, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nîmes, France
NCT02400437
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00570180
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
- CancerCare Manitoba 675 McDermot Ave. Winnipeg, Manitoba, Canada
- Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
- London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada
Completed
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01842308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00534118
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
NCT02555969
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States